Perjeta® (pertuzumab) first treatment for advanced breast cancer to extend surviv
Perjeta, in combination with Herceptin® (trastuzumab) and chemotherapy (docetaxel), can extend survival in women with previously untreated, advanced HER2-positive breast cancer to over four and...